›Portfolio Companies

Past, Present and Future Leaders

InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.

Our Companies


Contact

2710 Sand Hill Road, Suite 200
Menlo Park, CA 94025, USA
T: 650-854-8585
F: 650-854-4706

Early stage IT and Healthcare Investing

Gil Kliman

gilkliman

Managing Partner

"It’s a privilege to work with visionary entrepreneurs who are creating the technologies and procedures that define the future of medical care. And it’s exciting to help them craft business strategies that propel and transform their ideas into market penetration and real-world success."

InterWest Team

Current Investments

Prior Investments

Follow Gil

Gil's bio

Portfolio
Company News

Gil's
Perspective

Gil's Buzz

Gil's video

Gil joined InterWest in 1996 and has been a Managing Director since 1999.  As a leader of InterWest’s Life Sciences investment team, Gil pioneered InterWest’s highly successful ophthalmology franchise. He was an early investor in Avedro, Glaukos, LenSx, and IntraLase, category-creating ophthalmic companies that became standard-of-care for eye surgery around the world. 

Gil is also a successful digital health investor, building this important franchise for InterWest over the last fifteen years through multiple companies. He led the Series A of Epocrates, the industry-leading first mobile application for physicians, serving on the board through its 2011 IPO, and was the founding institutional investor in Doximity, helping to build it into the leading physician social network engaging over 70% of U.S. physicians with over one total million members. 

Gil invests in a broad array of healthcare opportunities, with a special interest in ophthalmology, digital health, and AI/robotics.  

 

He is a board member of Doximity, and a former board member and lead investor in Avedro (NASDAQ: AVDR, acquired by Glaukos), Glaukos (NYSE: GKOS), LenSx Lasers (acquired by Alcon), IntraLase (NASDAQ: ILSE, acquired by AMO), Venus Concept (NASDAQ: VERO) (formerly Restoration Robotics),  Neuronetics (NASDAQ: STIM) and GoCheck.

 

Gil serves on the board of Orbis International, a global not-for-profit organization focused on preventing blindness.

Gil is also a Founder and Program Director of Ophthovation, an ophthalmology innovation conference supported by a joint venture of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery.  Previously, he co-founded the Ophthalmology Innovation Summit (OIS), an ophthalmology business conference that he co-chaired from 2009 to 2018. 

A former practicing ophthalmologist, Dr. Kliman completed an ophthalmology residency at Wills Eye Hospital and a retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation fellow. He has a BA from Harvard University, an MD from the University of Pennsylvania and an MBA from Stanford University.

Representative Prior Investments

 

Avedro (AVDR; acquired by Glaukos), Epocrates (EPOC; acquired by Athenahealth),  INC Research (acquired by Avista Capital Partners), Inspire Pharmaceuticals (ISPH), IntraLase (ILSE; acquired by AMO), LenSx Lasers (acquired by Alcon), Spinal Dynamics (acquired by Medtronic), Spiration (acquired by Olympus Medical Systems)

Over the last 20 years I have had the privilege of diverse life experiences as a laser researcher, practicing physician, startup company founder, and technology venture capitalist. I most enjoy being on the front edge of new technology waves, looking over the horizon for non-obvious opportunities... What I find exciting is working alongside visionary entrepreneurs, thinking non-traditionally, and helping to identify creative strategies to make pioneering ventures even more successful.

Facebook Google+ Twitter Email LinkedIn Share